SEC Company Response from Translate Bio, Inc. (CIK 0001693415) — Apr 30, 2020
Translate Bio, Inc. (CIK 0001693415)
Date: April 30, 2020 · CIK: 0001693415 · Accession: 0001193125-20-128801
AI Filing Summary & Sentiment
File numbers found in text: 333-237159
Show Raw Text
CORRESP 1 filename1.htm CORRESP TRANSLATE BIO, INC. 29 Hartwell Avenue Lexington, MA 02421 April 30, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Translate Bio, Inc. Registration Statement on Form S-3 File No. 333-237159 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Translate Bio, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-237159), so that it may become effective at 4:00 p.m. Eastern time on May 4, 2020, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, TRANSLATE BIO, INC. By: /s/ Paul Burgess Name: Paul Burgess Title: Chief Legal Officer and Chief Operating Officer cc: Cynthia T. Mazareas Wilmer Cutler Pickering Hale and Dorr LLP